CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
A phase 1 study of heat/phenol-killed, E. coli -encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy
Authors
A. W. Burks
A. Grishin
+6 more
A. K. Henning
R. Lindblad
H. A. Sampson
S. H. Sicherer
D. Stablein
R. A. Wood
Publication date
1 January 2013
Publisher
Doi
Cite
View
on
PubMed
Abstract
Immunotherapy for peanut allergy may be limited by the risk of adverse reactions
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:1831cr54s
Last time updated on 24/11/2020
